ArticleMolecular and cellular pediatrics2026
Subcutaneous infliximab as a maintenance option in pediatric IBD: a real-world cohort including younger and lower-weight children.
Neele Ridder et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.